Please Wait

Applying Filters...

Looking for Nivolumab? Find Controlled & Modified Release used in Nivolumab to address drug delivery challenges on PharmaCompass.

Nivolumab

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

4 API Suppliers, 4 Listed Suppliers

DEVELOPMENTS

418 Drugs in Development

418 Drugs in Development

FINISHED DOSAGE FORMULATIONS

84 FDF Dossiers, 4 FDA Orange Book, 5 Europe, 3 Canada, 72 Australia

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 12 SPI Pharma, 1 Faran Shimi Pharmaceutical, 1 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 7 Actylis, 2 BASF, 5 Gangwal Chemicals, 1 Ingredion Pharma Solutions, 2 Kerry, 2 Microlex e.U, 1 Nanjing Bold Chemical, 1 Pluviaendo, 3 Roquette, 6 Seppic, 1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 1 Sigachi Industries

EXCIPIENTS BY APPLICATIONS

17 Fillers, Diluents & Binders, 12 Parenteral, 10 Solubilizers, 10 Direct Compression, 10 Chewable & Orodispersible Aids, 9 Taste Masking, 5 Co-Processed Excipients, 3 Granulation, 3 Topical, 3 Emulsifying Agents, 3 Thickeners and Stabilizers, 3 Disintegrants & Superdisintegrants, 2 API Stability Enhancers, 2 Film Formers & Plasticizers, 2 Surfactant & Foaming Agents, 2 Controlled & Modified Release, 1 Rheology Modifiers

DIGITAL CONTENT

9 DATA COMPILATION #PharmaFlow, 583 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 4 Finished Drug Prices, 19 Annual Reports

MARKET PLACE

6 APIs, 5 FDF Dossiers

Xls

Filters

Nivolumab

Filters

FILTER :

filter Company Reset all filters

4 All

01 4Actylis

filter Capability Reset all filters

filter Country Reset all filters

01

Actylis

SODIUM CITRATE DIHYDRATE MULTI-COMPENDIAL

Antibody Engineering

Not Confirmed

02

Actylis

SODIUM CITRATE DIHYDRATE USP-NF

Antibody Engineering

Not Confirmed